Biotechnology

IVF Life the first clinic group in Europe to use Artificial Intelligence to non-invasively assess the genetic integrity of embryos

ADELAIDE, Australia, May 25, 2021 /PRNewswire/ -- IVF Life Group, a leading group of IVF clinics acrossSpain, UK, and Germany, will be among the first in Europe to use Artificial Intelligence (AI) to non-invasively assess embryos to determine their genetic integrity. The AI product Life Whisperer...

2021-05-25 17:15 2093

Renowned international investor Jim Rogers joins Life3 Biotech's Board of Investors

SINGAPORE, May 25, 2021 /PRNewswire/ -- Renowned international investor Jim Rogers has joined Singapore-based food tech company, Life3 Biotech (Life3) as a member of its Board of Investors.

2021-05-25 16:30 2830

Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion

* SEEGENE POSTS KRW 193.9 BIL. IN OPERATING PROFIT, UP 388% ON-YEAR * OPERATING PROFIT RATIO AT 55%, DESPITE CONSTANT INVESTMENT IN R&D AND EMPLOYEES SEOUL, South Korea, May 25, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a molecular diagnostics company reported its financial results for th...

2021-05-25 15:33 12289

Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA

HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical Products Administration (NMPA), the clinical trial application of ASC40 combined with bevacizumab to treat patients with re...

2021-05-25 08:30 3736

Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development

SHANGHAI and HARTFORD, Conn., May 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and...

2021-05-25 08:00 4808

SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly

JENA, Germany, May 25, 2021 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, releases status updates ofSIRONA Randomized Control Trial (RCT) which compares head-to-head,SIROlimus versus Paclitaxel Drug-Eluting BallooN...

2021-05-25 07:03 4246

Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project

Lifebit's precision medicine software will power Hong Kong's development of genomic medicine by supporting the Hong Kong Genome Institute to implement the first large-scale genome sequencing initiative, the Hong Kong Genome Project. The Project will empower medical professionals and researchers t...

2021-05-25 06:00 4195

TruDiagnostic signs an exclusive license agreement with Duke University to use the DunedinPoAm rate of aging algorithm.

LEXINGTON, Ky. and DURHAM, N.C., May 24, 2021 /PRNewswire/ -- Today, TruDiagnostic signs an exclusive license agreement to the DunedinPoAm pace of aging methylation prediction algorithm. Pace of Aging is how quickly a person's epigenetic markers are changing to hasten or slow their progression of...

2021-05-24 20:30 1751

Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID

SEOUL, Korea, May 24, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID. Seegene's...

2021-05-24 09:58 2205

Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea

Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...

2021-05-23 00:39 10016

Recently Merged dMed and Clinipace Announce the Appointment of New Global COO

SHANGHAI and MORRISVILLE, N.C., May 21, 2021 /PRNewswire/ -- Following the recent merger announcement ofShanghai-based dMed Global and NC-based Clinipace Incorporated, the combined company today announced the appointment ofSimon Britton to the position of Chief Operating Officer (COO).  Britton w...

2021-05-21 20:00 6246

Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation LLC Announce Launch of Seoul Innovation QuickFire Challenge on Smart Surgery in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

- QuickFire Challenge calls on innovators to submit novel ideas with the potential to transform the surgical pathway for optimized care, cost savings, and improved patient outcomes. - Awardee(s) will receive grant funding from a total of up to KRW150,000,0001 , one year of residency at the Seoul ...

2021-05-21 05:00 3763

BioVaxys Announces Appointment of Policy Advisor

VANCOUVER, BC, May 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF)("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment ofAdam Coutts, PhD, as Policy ...

2021-05-20 20:00 12564

Everest Medicines Announces China NMPA Has Granted Priority Review for Sacituzumab Govitecan-hziy in Metastatic Triple-Negative Breast Cancer

SHANGHAI, May 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products inGreater China and other parts of Asia, announced today that sacit...

2021-05-20 19:04 6138

European Wellness and Dongci Join Forces To Bring Regenerative Medicine To Shandong, China

KOTA KINABALU, Malaysia, May 20, 2021 /PRNewswire/ -- European Wellness Biomedical Group has signed a memorandum of understanding (MOU) with Yantai Dongci ZhenAn Hospital Group to develop an exclusive multimillion dollar-project Regenerative Medicine Center inShandong, China. In a digital signin...

2021-05-20 16:54 3440

Alphamab Oncology to Present Multiple Clinical Research Data at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021)

SUZHOU, China, May 20, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced, data from three clinical studies of the PD-L1/CTLA-4 bispecific antibody KN046 will be presented in Poster session at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021) to be held...

2021-05-20 09:34 9228

ASCO 2021 | Ascentage Pharma to Announce Updated Data of Lisaftoclax (APG-2575) Demonstrating an ORR of Around 80% and Therapeutic Potential in Patients with R/R CLL/SLL in Oral Presentation

SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that an abstract reporting on...

2021-05-20 08:44 5632

ASCO 2021 | Ascentage Pharma to Announce Updated Results Demonstrating Clinical Potential of Alrizomadlin (APG-115) Plus Pembrolizumab in Patients with Advanced Solid Tumors that Had Failed Immunotherapies in Oral Presentation

SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that abstracts reporting on t...

2021-05-20 08:17 5923

Firmenich Enters Strategic Partnership with Essential Labs, LLC, a Leading B2B E-Commerce Supplier of Fragrance Solutions

GENEVA, May 18, 2021 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, has entered into a strategic partnership with Essential Labs, LLC, a leading B2B supplier of fragrance solutions supporting entrepreneurial, independent businesses in the premium home...

2021-05-18 23:00 2719

Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing

ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ad...

2021-05-18 21:00 2151

Week's Top Stories